Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil after PTA for dialysis AVF stenosis
ChiCTR1800016420Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mycophenolate mofetil in end-stage kidney disease (ESKD) and arteriovenous fistula stenosis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Primary patency rate and Restenosis rate. Planned start Jun 2018; status: not yet recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
end-stage kidney disease (ESKD)arteriovenous fistula stenosis
Beyond the preview
Go deeper on ChiCTR1800016420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016420.